Novo Nordisk in $812m pact with Deep Apple for oral small molecule
HQ Team June 11, 2025: Denmarkās Novo Nordisk A/S and US-based Deep Apple Therapeutics Inc. signed an $812 million agreement to develop an.
Climate
Health
Research
Drugs
Health
Pharma
Teva to sell generic version of Novo Nordiskās diabeticĀ drug in US
Israelās Teva Pharmaceuticals will start selling a generic version of Novo Nordiskās type 2 diabetic drug Victoza in the US market.